CapsoVision, Inc (CV) earnings date
Mar 25, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 35% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 44 days, typically, give or take 17 (last 6 releases) |
Last 6 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 12, 2026 | after close | 43 | 8-K |
| Q2 FY2026 | Thu, Aug 13, 2026 | after close | 44 | 8-K |
| Q1 FY2026 | Thu, May 14, 2026 | after close | 44 | 8-K |
| Q4 FY2025 | Thu, Mar 26, 2026 | after close | 85 | 8-K |
| Q3 FY2025 | Thu, Nov 13, 2025 | after close | 44 | 8-K |
| Q2 FY2025 | Thu, Aug 14, 2025 | after close | 45 | 8-K |
What they guided beta
| Q3 FY2026 | "The Company expects the addition of AI Highlights to accelerate CapsoCam Plus sales growth, with the full commercial impact anticipated in 2027." exhibit |
| Q3 FY2026 | "Raised approximately $1.7 million in net proceeds through the at-the-market offering program during the third quarter of 2026." exhibit |
| Q3 FY2026 | "The Company expects the addition of AI Highlights, launched on November 2, 2026, following FDA clearance, t o accelerate CapsoCam Plus sales growth, with the full commercial impact anticipated in 2027." exhibit |
| Q2 FY2026 | "Anticipate FDA clearance of AI Highlights™ by the end of the third quarter of 2026, with U.S. commercial launch expected shortly thereafter." exhibit |
| Q2 FY2026 | "Operating expenses were $9.5 million, a $3.0 million increase from the second quarter of 2025, driven primarily by expenses associated with the colon pivotal study and other clinical trials, non-recurring engineering services for the Canon development project, expenses for operating as a public company, and stock-based compensation." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/CV
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/CV
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/CV/"><img src="https://veritasdata.dev/embed/CV.svg" alt="CV earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/CV/)
Script
<script async src="https://veritasdata.dev/embed/CV.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/CV"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.